June, 14 2026 Sunday 13:54 Hrs
Last update 11-9-2025
  • SENSEX :   75,527.95

  • Commodity broking firm in India1,695.40( 2.30%) 12-Jun-2026
Positive
Sensex 75527.95 1695.40  (2.30) 12-Jun-2026
Previous Day Close 73832.55
Today's High/Low
High Low
  •  
  •  
75608.02 74453.39

Hot Pursuit - Detailed News

KIMS to issue 77 lakh warrants worth Rs 600 crore to promoters
13-Jun-26   14:18 Hrs IST

Each warrant is convertible into one equity share within 18 months from the date of allotment.

Of the total proposed issuance, 64.19 lakh warrants aggregating Rs 500 crore will be allotted to promoters Dr. Abhinay Bollineni and Mr. Advik Bollineni, while 12.84 lakh warrants aggregating Rs 100 crore will be allotted to promoter-group entity Bharas Ventures LLP.

The proposal remains subject to shareholder approval and other regulatory clearances. The company has also scheduled an extra-ordinary general meeting (EGM) for 09 July 2026 to seek shareholder consent for the same.

Assuming 100% conversion of warrants, shareholding of Dr. Abhinay Bollineni will rise to 0.84% from 0.06% currently, and that of Adwik Bollineni will climb to 0.80% from 0.01%.

Bharas Ventures LLP will own 0.31% stake in the company post warrant conversion. Bharas Ventures is a limited liability partnership between the company's two promoters, viz., Dr. Bhaskara Rao Bollineni and Ms. Rajyasri Bollineni.

Headquartered in Hyderabad, Krishna Institute of Medical Sciences (KIMS Hospitals) is one of the largest corporate healthcare groups in Telangana and Andhra Pradesh, providing multi-disciplinary integrated healthcare services, with a focus on tertiary and quaternary healthcare at affordable cost.

The company's consolidated net profit declined 58.25% to Rs 42.50 crore despite a 34.85% increase in revenue to Rs 1,074.60 crore in Q4 FY26 over Q4 FY25.

The scrip fell 2.88% to end at Rs 787.10 on the BSE on Friday.

Powered by Capital Market - Live News

Top

Attention Investor:

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.